Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cetuximab, EGFR HNSCC

Ezra Cohen

MD

🏢UC San Diego Moores Cancer Center🌐USA

Associate Director, Translational Science

54
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ezra Cohen at UC San Diego is a leading HNSCC clinical researcher who has contributed to studies of cetuximab, EGFR-targeted therapies, and novel immunotherapy combinations in head and neck cancer. His work has addressed the molecular underpinnings of EGFR dependence and mechanisms of cetuximab resistance in HNSCC. He has participated in multiple phase I-III trials evaluating novel agents and combinations for recurrent and metastatic disease. He is recognized for his contributions to translational HNSCC biomarker research.

Share:

🧪Research Fields 研究领域

cetuximab HNSCC
EGFR-targeted therapy HNSCC
EXTREME regimen
biomarkers HNSCC
immunotherapy HNSCC combinations

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Ezra Cohen 的研究动态

Follow Ezra Cohen's research updates

留下邮箱,当我们发布与 Ezra Cohen(UC San Diego Moores Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment